Nilemdo
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nilemdo, covering 2025-04-11 to 2026-02-27. Get the full timeline:
Most recent: EMA Authorised: Nilemdo (bempedoic acid) — Daiichi Sankyo Europe GmbH